Sanara MedTech (SMTI) Shares Outstanding (Weighted Average) (2010 - 2026)

Sanara MedTech has reported Shares Outstanding (Weighted Average) for 17 years, with the latest figure at $8.7 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 1.59% year-over-year to $8.7 million; the trailing twelve-month figure through Mar 2026 stood at $8.7 million (up 1.59% YoY), and the FY2025 full-year result was $8.6 million, up 1.64% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $8.7 million, up from $8.6 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $8.7 million in Q1 2026, with the low at $7.6 million in Q1 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $8.3 million across 5 years, with a median of $8.4 million in 2024.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) gained 11.59% — and 2025, when it gained 1.52%.
• Sanara MedTech's Shares Outstanding (Weighted Average) stood at $7.9 million in 2022, then grew by 4.71% to $8.3 million in 2023, then advanced by 2.48% to $8.5 million in 2024, then gained by 1.64% to $8.6 million in 2025, then gained by 0.97% to $8.7 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $8.7 million (Q1 2026), $8.6 million (Q4 2025), and $8.6 million (Q3 2025), per Business Quant data.